Jim Huntington Archives – Cambridge Enterprise

Three Cambridge spin-outs join Centessa Pharmaceuticals, launched today with a $250m Series A round

16 February 2021

Cambridge spin-out ApcinteX shares clinical trial results from its study of SerpinPC

05 February 2021

Cambridge spin-out ApcinteX begins dosing haemophilia patients in second part of clinical trial

Cambridge spin-out ApcinteX starts clinical trials of novel haemophilia drug

22 October 2019

Annual awards recognise Cambridge innovation and excellence

Spin-out Z Factor announces £7 million Series A funding to bring lung treatment to the clinic

Cambridge Enterprise joins in £14m funding round for spin-out ApcinteX Limited

02 February 2017

XO1

Potential new treatment for haemophilia developed by Cambridge researchers

27 October 2016

XO1

X01 and a ground-breaking drug candidate

20 October 2015

X01: towards the ‘holy grail’ of anticoagulant drugs